These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27357914)

  • 1. Haemostatic biomarkers are associated with long-term recurrent vascular events after ischaemic stroke.
    Pedersen A; Redfors P; Lundberg L; Gils A; Declerck PJ; Nilsson S; Jood K; Jern C
    Thromb Haemost; 2016 Aug; 116(3):537-43. PubMed ID: 27357914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men.
    Wannamethee SG; Whincup PH; Lennon L; Rumley A; Lowe GD
    Stroke; 2012 May; 43(5):1206-11. PubMed ID: 22382157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased fibrinogen, von Willebrand factor and tissue plasminogen activator levels in insulin resistant South Asian patients with ischaemic stroke.
    Kain K; Catto AJ; Young J; Bamford J; Bavington J; Grant PJ
    Atherosclerosis; 2002 Aug; 163(2):371-6. PubMed ID: 12052485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
    Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostasis in ischaemic stroke and vascular dementia.
    Stott DJ; Spilg E; Campbell AM; Rumley A; Mansoor MA; Lowe GD
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):651-7. PubMed ID: 11734665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants.
    Smith FB; Rumley A; Lee AJ; Leng GC; Fowkes FG; Lowe GD
    Br J Haematol; 1998 Mar; 100(4):758-63. PubMed ID: 9531345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic influences on fibrinogen, tissue plasminogen activator-antigen and von Willebrand factor in males and females.
    de Lange M; de Geus EJ; Kluft C; Meijer P; van Doornen LJ; Boomsma DI; Snieder H
    Thromb Haemost; 2006 Mar; 95(3):414-9. PubMed ID: 16525567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemostatic markers of endothelial injury in ischaemic stroke caused by large or small vessel disease].
    Iskra T; Turaj W; Słowik A; Zwolińska G; Strojny J; Szczudlik A
    Pol Merkur Lekarski; 2006 Nov; 21(125):429-33. PubMed ID: 17345834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection.
    Sosothikul D; Seksarn P; Pongsewalak S; Thisyakorn U; Lusher J
    Thromb Haemost; 2007 Apr; 97(4):627-34. PubMed ID: 17393026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
    Vene N; Mavri A; Kosmelj K; Stegnar M
    Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.
    Jansson JH; Nilsson TK; Johnson O
    Heart; 1998 Oct; 80(4):334-7. PubMed ID: 9875107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
    Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
    Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial haemostatic factors may be associated with mortality in patients on long-term anticoagulant treatment.
    Brännström M; Jansson JH; Boman K; Nilsson TK
    Thromb Haemost; 1995 Aug; 74(2):612-5. PubMed ID: 8584993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in hemostatic markers after recombinant tissue-type plasminogen activator is not associated with the chance of recanalization.
    Martí-Fàbregas J; Borrell M; Cocho D; Martínez-Ramírez S; Martínez-Corral M; Fontcuberta J; Martí-Vilalta JL
    Stroke; 2008 Jan; 39(1):234-6. PubMed ID: 18048863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
    Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
    J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic risk factors for cardiovascular diseases.
    Koenig W
    Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating t-PA antigen predicts major adverse coronary events in patients with stable coronary artery disease--a 13-year follow-up.
    Niessner A; Graf S; Nikfardjam M; Speidl WS; Huber-Beckmann R; Zorn G; Wojta J; Huber K
    Thromb Haemost; 2003 Aug; 90(2):344-50. PubMed ID: 12888883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum vWF and sVCAM-1 levels are associated with late or very late angiographic stent thrombosis after sirolimus-eluting stent implantation.
    Jin C; Lu L; Zhu ZB; Zhang RY; Zhang Q; Du R; Ding FH; Chen QJ; Shen WF
    Coron Artery Dis; 2010 Aug; 21(5):273-7. PubMed ID: 20508517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.